ALEC Stock Tanks as Alzheimer's Drug Fails in Mid-Stage Study
Alector stock falls as the phase II INVOKE-2 study evaluating AL002 in slowing disease progression in early Alzheimer's disease fails to meet the primary goal.
Meticulous Market Research Pvt. Ltd.: Dietary Supplements Market to Reach $166.58 Billion by 2031 - Exclusive Report by Meticulous Research
According to a new market research report titled, 'Dietary Supplements Market Size, Share, Forecast, & Trends Analysis by Type (Botanicals, Minerals ...
Dietary Supplements Market to Reach $166.58 Billion by 2031 - Exclusive Report by Meticulous Research®
According to a new market research report titled, 'Dietary Supplements Market Size, Share, Forecast, & Trends Analysis by ...
BeiGene announces EC approval of Tevimbra
BeiGene (BGNE) announced that the European Commission has approved Tevimbra in combination with chemotherapy for the first-line treatment of ...